Steven A. Gould
Algemeen Directeur bij Helus, Inc.
Profiel
Steven A.
Gould is currently the Chief Executive Officer & Director at Helus, Inc. and the Director at Innovation Development Institute, Inc. He was previously the Chairman & Chief Executive Officer at Northfield Laboratories, Inc. from 1993 to 2009 and an Operating Partner at Abundant Venture Partners LLC from 2016 to 2019.
Gould received his doctorate degree from Boston University in 1973 and his undergraduate degree from Williams College in 1968.
Actieve functies van Steven A. Gould
Bedrijven | Functie | Begin |
---|---|---|
Innovation Development Institute, Inc.
Innovation Development Institute, Inc. Electronic Equipment/InstrumentsElectronic Technology Innovation Development Institute, Inc. operates as a community of healthcare innovators who aspire to heroic change. The company is headquartered in Chicago, IL. | Directeur/Bestuurslid | 01-01-2013 |
Helus, Inc.
Helus, Inc. Internet Software/ServicesTechnology Services Helus, Inc. offers secure communication, content exchange, electronic commerce and clinical workflow for community-based physician practices. The company is headquartered in Chicago, IL. | Algemeen Directeur | - |
Eerdere bekende functies van Steven A. Gould
Bedrijven | Functie | Einde |
---|---|---|
Abundant Venture Partners LLC
Abundant Venture Partners LLC Investment ManagersFinance Abundant Venture Partners LLC (Abundant Venture Partners) is a venture capital firm founded in 2011 by Andrew Swinand and Eric Langshur. The firm is headquartered in Chicago, Illinois. | Private Equity Investor | 31-12-2019 |
Northfield Laboratories, Inc.
Northfield Laboratories, Inc. BiotechnologyHealth Technology The Company's principal activity is to develop, manufacture, market and distribute a hemoglobin-based blood substitute product. The Company's product, PolyHeme(R) blood substitute, provides an alternative to transfused blood for use in the treatment of acute blood loss. The company uses a proprietary process of separation, filtration, chemical modification purification and formulation to produce PolyHeme. PolyHeme is designed to avoid potential undesirable effects such as vasoconstriction, kidney dysfunction, liver dysfunction and gastrointestinal distress. Clinical trials of PolyHeme have been conducted at multiple locations in the United States. The company has entered into license agreements with Pfizer Inc and Hemocare Ltd an Israeli corporation to develop manufacture and distribute PolyHeme in certain European, Middle Eastern and African countries. The Company is in development stage. | Voorzitter | 10-11-2009 |
Opleiding van Steven A. Gould
Boston University | Doctorate Degree |
Williams College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 4 |
---|---|
Northfield Laboratories, Inc.
Northfield Laboratories, Inc. BiotechnologyHealth Technology The Company's principal activity is to develop, manufacture, market and distribute a hemoglobin-based blood substitute product. The Company's product, PolyHeme(R) blood substitute, provides an alternative to transfused blood for use in the treatment of acute blood loss. The company uses a proprietary process of separation, filtration, chemical modification purification and formulation to produce PolyHeme. PolyHeme is designed to avoid potential undesirable effects such as vasoconstriction, kidney dysfunction, liver dysfunction and gastrointestinal distress. Clinical trials of PolyHeme have been conducted at multiple locations in the United States. The company has entered into license agreements with Pfizer Inc and Hemocare Ltd an Israeli corporation to develop manufacture and distribute PolyHeme in certain European, Middle Eastern and African countries. The Company is in development stage. | Health Technology |
Innovation Development Institute, Inc.
Innovation Development Institute, Inc. Electronic Equipment/InstrumentsElectronic Technology Innovation Development Institute, Inc. operates as a community of healthcare innovators who aspire to heroic change. The company is headquartered in Chicago, IL. | Electronic Technology |
Helus, Inc.
Helus, Inc. Internet Software/ServicesTechnology Services Helus, Inc. offers secure communication, content exchange, electronic commerce and clinical workflow for community-based physician practices. The company is headquartered in Chicago, IL. | Technology Services |
Abundant Venture Partners LLC
Abundant Venture Partners LLC Investment ManagersFinance Abundant Venture Partners LLC (Abundant Venture Partners) is a venture capital firm founded in 2011 by Andrew Swinand and Eric Langshur. The firm is headquartered in Chicago, Illinois. | Finance |